St. Louis-based Biomedical Systems focuses on research innovations in centralized cardiac safety, pulmonary function, imaging, scientific affairs and electronic clinical outcome assessment (eCOA).
Lee Spurgin, Jr., PhD, SVP and General Manager, Medical Device and Diagnostic Development at Theorem told Outsourcing-Pharma.com, “Biomedical Systems can assist Theorem with a wide variety of studies that include imaging and core lab services. Focused on our core therapeutic strength we are using Biomedical Systems for cardiovascular, oncology, CNS and respiratory studies but will expand as needed. They can provide services in the America’s, Western Europe and parts of Asia.”
Biomedical Systems also will look to expand Theorem’s reach, with a European office in Brussels, with logistical support facilities in Japan and India and investigative sites in almost 100 countries. Theorem Clinical Research has offices in more than 30 countries worldwide, offering deep expertise in a broad range of therapeutic areas and all phases of development.
The partnership also doesn’t have a firm timeline for when it expects specific results. Spurgin told us: “As an alliance, we have established governance that reviews a wide variety of metrics. There is no timeline to the partnership, but a desire to build long term success.”
And in terms of what specifically Biomedical will offer in the partnership, Tim Barrett, CEO of Biomedical Systems explained to us that his company “is a core lab providing a comprehensive suite of centralized diagnostic services in cardiac safety, pulmonary, imaging, scientific affairs and ePRO globally.”
The partnership comes as last month Theorem formed a strategic alliance with BioTelemetry to supplement its cardiovascular testing services. Theorem also recently joined ACRO (Association of Clinical Research Organizations) as a new member.